You are here
Clinical Trials: Cord Blood
Discuss
Condition: Acute Myeloid Leukemia
Intervention: Biological: Unrelated cord blood
Sponsors: Ruijin Hospital; Navy General Hospital of PLA; Beijing Jishuitan Hospital; The Affiliated Hospital of Xuzhou Medical University; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Luoyang Central Hospital; People's Hospital of Zhengzhou University; Dongguan People's Hospital; The First Affiliated Hospital of Xiamen University; Taian City Central Hospital; Qilu Hospital of Shandong University (Qingdao)
Recruiting
Intervention: Biological: Unrelated cord blood
Sponsors: Ruijin Hospital; Navy General Hospital of PLA; Beijing Jishuitan Hospital; The Affiliated Hospital of Xuzhou Medical University; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Luoyang Central Hospital; People's Hospital of Zhengzhou University; Dongguan People's Hospital; The First Affiliated Hospital of Xiamen University; Taian City Central Hospital; Qilu Hospital of Shandong University (Qingdao)
Recruiting
Conditions: High Risk Hematologic Malignancy; Cord Blood Transplant
Intervention: Biological: Transplant with an expanded ECT-001 cord blood
Sponsors: Ciusss de L'Est de l'Île de Montréal; Stem Cell Network (SCN); Hopital de l'Enfant-Jesus; Centre Universitaire de Santé McGill; ExCellThera inc.
Not yet recruiting
Intervention: Biological: Transplant with an expanded ECT-001 cord blood
Sponsors: Ciusss de L'Est de l'Île de Montréal; Stem Cell Network (SCN); Hopital de l'Enfant-Jesus; Centre Universitaire de Santé McGill; ExCellThera inc.
Not yet recruiting
Conditions: Hematological Malignancy; Acute Leukemia in Remission; Acute Lymphoblastic Leukemia in Remission; Myelodysplastic Syndromes; Non-Hodgkin Lymphoma; Hodgkin Lymphoma
Interventions: Biological: Cord blood stem cells; Drug: Valproic Acid; Drug: Fludarabine; Drug: cytoxan; Drug: Thiotepa; Biological: TBI
Sponsor: Alla Keyzner
Recruiting
Interventions: Biological: Cord blood stem cells; Drug: Valproic Acid; Drug: Fludarabine; Drug: cytoxan; Drug: Thiotepa; Biological: TBI
Sponsor: Alla Keyzner
Recruiting
Conditions: Diabetes Mellitus, Type 1; Immunologic Deficiency Syndromes
Intervention: Procedure: Sequential transplantation
Sponsor: Children's Hospital of Fudan University
Not yet recruiting
Intervention: Procedure: Sequential transplantation
Sponsor: Children's Hospital of Fudan University
Not yet recruiting
Condition: Cerebral Palsy
Interventions: Biological: CP CB-MNC injection; Other: Standard therapy
Sponsor: State-Financed Health Facility "Samara Regional Medical Center Dinasty"
Enrolling by invitation
Interventions: Biological: CP CB-MNC injection; Other: Standard therapy
Sponsor: State-Financed Health Facility "Samara Regional Medical Center Dinasty"
Enrolling by invitation
Conditions: Acute Myelogenous Leukemia; Allogeneic Stem Cell Transplantation
Intervention: Drug: Bisantrene
Sponsors: Sheba Medical Center; Race Oncology Ltd
Not yet recruiting
Intervention: Drug: Bisantrene
Sponsors: Sheba Medical Center; Race Oncology Ltd
Not yet recruiting
Condition: Osteoarthritis, Knee
Interventions: Drug: Hyaluronic Acid; Biological: Umbilical Cord Mesenchymal Stem Cell; Biological: Recombinant Human Somatropin
Sponsor: Indonesia University
Recruiting
Interventions: Drug: Hyaluronic Acid; Biological: Umbilical Cord Mesenchymal Stem Cell; Biological: Recombinant Human Somatropin
Sponsor: Indonesia University
Recruiting
Condition: Rheumatoid Arthritis
Intervention: Biological: UC-MSCs
Sponsors: Xijing Hospital; Changhai Hospital; Southwest Hospital, China
Recruiting
Intervention: Biological: UC-MSCs
Sponsors: Xijing Hospital; Changhai Hospital; Southwest Hospital, China
Recruiting
Condition: Hypoplastic Left Heart Syndrome
Interventions: Biological: Autologous (self) mononuclear cells derived from umbilical cord blood; Procedure: Stage II Surgical repair
Sponsors: Timothy J. Nelson; University of Oklahoma; Children's Hospital of Philadelphia; Children's Hospital Los Angeles; Children's Hospital Colorado; Children's Hospitals and Clinics of Minnesota
Not yet recruiting
Interventions: Biological: Autologous (self) mononuclear cells derived from umbilical cord blood; Procedure: Stage II Surgical repair
Sponsors: Timothy J. Nelson; University of Oklahoma; Children's Hospital of Philadelphia; Children's Hospital Los Angeles; Children's Hospital Colorado; Children's Hospitals and Clinics of Minnesota
Not yet recruiting
Condition: Psoriasis
Interventions: Biological: Mesenchymal Stem Cells; Drug: Oral Methotrexate
Sponsor: Central South University
Not yet recruiting
Interventions: Biological: Mesenchymal Stem Cells; Drug: Oral Methotrexate
Sponsor: Central South University
Not yet recruiting
